アロマターゼ阻害剤の開発とその作用機作の解析

スポンサーリンク

概要

• 論文の詳細を見る

• Inhibitors of aromatase are of interest in the treatment of advanced estrogen-dependent breast cancers. In addition, the inhibitors are promising to play as conformational and catalytic probes for the active site of this enzyme, aromatase. There fore, we synthesized a number of steroidal aromatase inhibitors, including suicide substrates, and also studied the mechanism for a time-dependent inactivation of aromatase by the suicide substrates. The mechanism for the aromatase inactivation by 6-oxo-androstenedione (AD) (1), one of the first discovered suicide substrates, was explored using the 19-substituted analogs 2-5 as well as stereo- and/or regio-specifically labeled [^3H, ^<14>C]- compound 1. The results indicated that the 4β, 5β-epoxy-19-oxo derivative 7 is a reactive electrophile that irreversibly binds to the active site of aromatase. Studies on the aromatase inhibition by regioisomers of AD, 4-en-6-one 17,5-en-4-one 18 and 5-en-7-one 19,revealed that the C-3 carbonyl function is not essential for the tight binding of an inhibitor to the active site. 3-Deoxy AD (22) and its 6α, 7α-cyclopropano steroid 24 as well as some of 6-alkyl-ADs are among the most potent competitive inhibitors reported so for (K_m for AD/K_i>6). Structure-activity relationships of the 6-alkyl-ADs and their 3-deoxy-, Δ^1-, Δ^6-, and Δ^<1,6>-analogs as aromatase inhibitors showed that aromatase has a hydrophobic binding pocket with a limited accessible volume in the active site in the region corresponding to the β-side rather than the α-side of the C-6 position of the substrate. The 6-alkyl-ADs and their Δ^1-analogs were converted into the corresponding estrogens with human placental aromatase, whereas the 3-deoxy steroids 22 and 25 were metabolized to the corresponding 19-oxygenated compounds. The relative apparent K_m values for the androgens are different from the relative K_i values, indicating that there is a difference between the ability to serve as an inhibitor and that to serve as a substrate. Moreover, it seems likely that the alignment of the substrate AD analogs in the active site would be markedly different from that of the 3-deoxy steroids.

• 公益社団法人日本薬学会の論文
• 1998-12-01

著者

• 沼澤 光輝

  東北薬科大学薬学部臨床分析化学教室

• 沼澤 光輝

  東北薬科大学

関連論文

• 原発性アルドステロン症診断におけるアルドステロン微量測定の意義
• デテロイド性疾患と抗ステロイド剤
• 2,2-Dimethylanodrostenedioneのアロマターゼ反応におけるメタボリックスイッチングに関する研究 : 予測代謝物の合成とアロマターゼ阻害活性
• Androst-4-ene-17-thioneとその5-ene異性体の合成とアロマターゼ阻害活性
• アロマターゼ阻害剤の開発とその作用機作の解析
• 1,4-Diene,4,6-Diene または 1,4,6-Triene 構造を持つアロマターゼ阻害剤 6-Phenylaliphatic C_19 Steroid の分子モデリング
• 5β,6β-Epoxyandrosta-4,7,17-trioneによるヒト胎盤ミクロゾーム中アロマターゼの時間依存的不活性化
• リパーゼ触媒によるステロイドアルコールのアセチル化とアセテートの加水分解

スポンサーリンク